These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Bethanechol as a Corrective for Urinary Retention Associated With Olanzapine Administration. Greco FA; Simms NJ; Athappilly GK Prim Care Companion CNS Disord; 2019 Oct; 21(5):. PubMed ID: 31682336 [No Abstract] [Full Text] [Related]
25. Safety of olanzapine use in adolescents. Schulz C; Haight RJ Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012 [TBL] [Abstract][Full Text] [Related]
26. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
27. Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Vera-Llonch M; Delea TE; Richardson E; Rupnow M; Grogg A; Oster G Value Health; 2004; 7(5):569-84. PubMed ID: 15367252 [TBL] [Abstract][Full Text] [Related]
28. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914 [TBL] [Abstract][Full Text] [Related]
30. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
31. Prolongation of clozapine-induced leukopenia with olanzapine treatment. Sayin A; Cosar B Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295 [TBL] [Abstract][Full Text] [Related]
32. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
34. Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia. Bhanji NH; Margolese HC Can J Psychiatry; 2004 May; 49(5):343. PubMed ID: 15198472 [No Abstract] [Full Text] [Related]
35. Priapism Associated With Antipsychotic Medication Use: Case Report. Fu E; Kovach JG; Dubin WR J Clin Psychopharmacol; 2017 Aug; 37(4):477-478. PubMed ID: 28590368 [No Abstract] [Full Text] [Related]
36. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]
37. Olanzapine: a review of rapid and long-acting parenteral formulations. Owen RT Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591 [TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol. Parabiaghi A; Tettamanti M; D'Avanzo B; Barbato A; Acta Psychiatr Scand; 2016 Jan; 133(1):63-75. PubMed ID: 26252780 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Chrzanowski WK; Marcus RN; Torbeyns A; Nyilas M; McQuade RD Psychopharmacology (Berl); 2006 Dec; 189(2):259-66. PubMed ID: 17058105 [TBL] [Abstract][Full Text] [Related]
40. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]